No paralogue variants have been mapped to residue 171 for KCNJ2.
| KCNJ2 | TTIGYGFRCVTDECPIAVFMVVFQSIVGCI>I<DAFIIGAVMAKMAKPKKRNETLVFSHNAVI | 201 |
| KCNJ1 | VTIGYGFRCVTEQCATAIFLLIFQSILGVI>I<NSFMCGAILAKISRPKKRAKTITFSKNAVI | 200 |
| KCNJ3 | ATIGYGYRYITDKCPEGIILFLFQSILGSI>V<DAFLIGCMFIKMSQPKKRAETLMFSEHAVI | 202 |
| KCNJ4 | TTIGYGFRCVTEECPLAVIAVVVQSIVGCV>I<DSFMIGTIMAKMARPKKRAQTLLFSHHAVI | 193 |
| KCNJ5 | TTIGYGFRVITEKCPEGIILLLVQAILGSI>V<NAFMVGCMFVKISQPKKRAETLMFSNNAVI | 208 |
| KCNJ6 | TTIGYGYRVITDKCPEGIILLLIQSVLGSI>V<NAFMVGCMFVKISQPKKRAETLVFSTHAVI | 211 |
| KCNJ8 | VTIGFGGRMMTEECPLAITVLILQNIVGLI>I<NAVMLGCIFMKTAQAHRRAETLIFSRHAVI | 199 |
| KCNJ9 | TTIGYGHRVITDQCPEGIVLLLLQAILGSM>V<NAFMVGCMFVKISQPNKRAATLVFSSHAVV | 179 |
| KCNJ10 | TTIGYGFRYISEECPLAIVLLIAQLVLTTI>L<EIFITGTFLAKIARPKKRAETIRFSQHAVV | 187 |
| KCNJ11 | VTIGFGGRMVTEECPLAILILIVQNIVGLM>I<NAIMLGCIFMKTAQAHRRAETLIFSKHAVI | 189 |
| KCNJ12 | TTIGYGLRCVTEECPVAVFMVVAQSIVGCI>I<DSFMIGAIMAKMARPKKRAQTLLFSHNAVV | 202 |
| KCNJ13 | LTIGYGTMFPSGDCPSAIALLAIQMLLGLM>L<EAFITGAFVAKIARPKNRAFSIRFTDTAVV | 178 |
| KCNJ14 | TSIGYGVRSVTEECPAAVAAVVLQCIAGCV>L<DAFVVGAVMAKMAKPKKRNETLVFSENAVV | 206 |
| KCNJ15 | TTIGYGVRSITEECPHAIFLLVAQLVITTL>I<EIFITGTFLAKIARPKKRAETIKFSHCAVI | 186 |
| KCNJ16 | TTIGYGYRCVTEECSVAVLMVILQSILSCI>I<NTFIIGAALAKMATARKRAQTIRFSYFALI | 190 |
| cons | > < |
| Protein | CDS | Disease Classification | Disease | dbSNP links | Effect Prediction |
|---|---|---|---|---|---|
| p.I171V | c.511A>G | Putative Benign | rs150326473 | SIFT: tolerated Polyphen: benign |